Bioregenx annual gross profit
2021
2022
2023
2024
2025
Bioregenx Gross Profit Growth & History (BRGX)
Bioregenx's gross profit was $1.5M for fiscal 2025.
View full Bioregenx company overviewBioregenx annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.5M | −$154,763 | −9.33% |
| 2024 | 2024-12-31 | $1.7M | −$653,007 | −28.25% |
| 2023 | 2023-12-31 | $2.3M | $2.3M | +5382.64% |
| 2022 | 2022-12-31 | $42,159 | −$155,871 | −78.71% |
| 2021 | 2021-12-31 | $198,030 | — | — |
Bioregenx quarterly gross profit
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | $348,288 | −$57,743 | −14.22% |
| Q4 2025 | 2025-12-31 | $318,774 | −$3,963 | −1.23% |
| Q3 2025 | 2025-09-30 | $426,397 | −$55,251 | −11.47% |
| Q2 2025 | 2025-06-30 | $352,456 | −$117,422 | −24.99% |
| Q1 2025 | 2025-03-31 | $406,031 | $21,873 | +5.69% |
| Q4 2024 | 2024-12-31 | $322,737 | −$55,288 | −14.63% |
| Q3 2024 | 2024-09-30 | $481,648 | −$89,553 | −15.68% |
| Q2 2024 | 2024-06-30 | $469,878 | −$128,433 | −21.47% |
| Q1 2024 | 2024-03-31 | $384,158 | −$379,733 | −49.71% |
| Q4 2023 | 2023-12-31 | $378,025 | — | — |
| Q3 2023 | 2023-09-30 | $571,201 | — | — |
| Q2 2023 | 2023-06-30 | $598,311 | — | — |
| Q1 2023 | 2023-03-31 | $763,891 | — | — |
Bioregenx gross profit trends
Between the periods ended 2021-12-31 and 2025-12-31, Bioregenx's gross profit increased from $198,030 to $1.5M, a change of $1.3M. The latest reported quarter, Q1 2026, shows $348,288.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bioregenx source filings ↗